The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010
Authors:
- Quinn T. OstromQOQuinn T. Ostrom
- Yanwen ChenYCYanwen Chen
- Peter M. de BlankPBPeter M. de Blank
- Annie OndracekAOAnnie Ondracek
- Paul FarahPFPaul Farah
- Haley GittlemanHGHaley Gittleman
- Yingli WolinskyYWYingli Wolinsky
- Carol KruchkoCKCarol Kruchko
- Mark L. CohenMCMark L. Cohen
- Daniel J. BratDBDaniel J. Brat
- Jill S. Barnholtz-SloanJBJill S. Barnholtz-Sloan
Open Access
- 20 May 2014
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 16 (10) , 1392-1399
Abstract
Background Atypical teratoid/rhabdoid tumor is a rare malignant CNS tumor that most often affects children ≤3 years old. The Central Brain Tumor Registry of the United States contains the largest aggregation of population-based incidence data for primary CNS tumors in the US. Its data were used to describe the incidence, associated trends, and relative survival after diagnosis of atypical teratoid/rhabdoid tumor. Methods Using data from 50 cancer registries between 2001 and 2010, age-adjusted incidence rates per 100 000 and 95% CIs were calculated by sex, race, Hispanic ethnicity, age at diagnosis, and location of tumor in the CNS for children aged 0 to 19 years. Relative survival rates and 95% CIs were also calculated. Results The average annual age-adjusted incidence rate was 0.07 (95% CI: 0.07, 0.08). Incidence rates did not significantly vary by sex, race, or ethnicity. Age had a strong effect on incidence rate, with highest incidence among children Conclusion We confirm differences in survival by age at diagnosis, treatment pattern, and location of tumor in the brain. This contributes to our understanding of these tumors and may stimulate research leading to improved treatment of this devastating childhood disease.Keywords
This publication has 27 references indexed in Scilit:
- Sequencing of Local Therapy Affects the Pattern of Treatment Failure and Survival in Children With Atypical Teratoid Rhabdoid Tumors of the Central Nervous SystemInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future DirectionsFrontiers in Oncology, 2012
- The Clone Wars – Revenge of the Metastatic Rogue State: The Sarcoma ParadigmFrontiers in Oncology, 2012
- Incidence of atypical teratoid/rhabdoid tumors in childrenCancer, 2010
- Childhood Atypical Teratoid Rhabdoid Tumor of the Central Nervous SystemJournal of Pediatric Hematology/Oncology, 2009
- Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid TumorJournal of Clinical Oncology, 2009
- Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based ChemotherapyJournal of Clinical Oncology, 2005
- Central Nervous System Atypical Teratoid/Rhabdoid Tumor: Results of Therapy in Children Enrolled in a RegistryJournal of Clinical Oncology, 2004
- Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System: A Highly Malignant Tumor of Infancy and Childhood Frequently Mistaken for MedulloblastomaAmerican Journal of Surgical Pathology, 1998
- Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entityJournal of Neurosurgery, 1996